Cognizant (CTSH) Up 6.7% Since Last Earnings Report: Can It Continue?

28.11.25 17:30 Uhr

Werte in diesem Artikel
Aktien

66,33 EUR 0,18 EUR 0,27%

Indizes

PKT PKT

25.434,9 PKT 198,0 PKT 0,78%

1.854,4 PKT -8,4 PKT -0,45%

6.849,1 PKT 36,5 PKT 0,54%

A month has gone by since the last earnings report for Cognizant (CTSH). Shares have added about 6.7% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Cognizant due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.Cognizant Q3 Earnings Beat Estimates, Revenues Up Y/YCognizant Technology Solutions reported non-GAAP earnings of $1.39 per share in the third quarter of 2025, which beat the Zacks Consensus Estimate by 7.75% and increased 11.2% year over year. Revenues of $5.42 billion beat the consensus mark by 1.63%. The top line increased 7.4% year over year and 6.5% at constant currency (cc). This growth was driven by strong performance in North America and organic growth across all segments. Acquisitions also contributed approximately 250 basis points to year-over-year revenue growth.On a trailing 12-month basis, bookings increased 5% year over year to $27.5 billion, which represented a book-to-bill of approximately 1.3 times. Bookings in the third quarter declined 5% year over year. Third-quarter bookings included six large deals, with a total contract value of more than $100 million.Cognizant had over 3,500 early Generative AI client engagements in the third quarter of 2025. This represents a 40% jump sequentially.CTSH’s Top-Line DetailsFinancial services revenues (29.1% of revenues) increased 6.2% year over year (up 5.4% at cc) to $1.578 billion. Growth is primarily driven by improved discretionary spending and investments in cloud, data modernization and AI.Health Sciences revenues (29.6% of revenues) increased 5.9% year over year (up 5.1% at cc) to $1.604 billion. Growth is driven by strong demand across payer, provider and life sciences, which offsets some discretionary spending pressures.Products and Resources revenues (25.5% of revenues) increased 12.6% year over year (up 11.4% at cc) to $1.383 billion.Communications, Media and Technology revenues (15.7% of revenues) were $850 million, which increased 4.2% from the year-ago quarter (up 3.6% at cc). Region-wise, revenues from North America increased 7.8% year over year and at cc and contributed 74.4% of total revenues.Revenues from Europe increased 7.8% year over year (up 2.7% at cc) and contributed 19.2% to total revenues. Revenues from the U.K. increased 4.4% year over year (up 0.7% at cc). Continental Europe revenues increased 11.1% year over year (up 4.6% at cc).The Rest of the World revenues increased 0.9% year over year (up 2.6% at cc) and contributed 6.4% to total revenues.CTSH’s Operating DetailsSelling, general & administrative expenses, as a percentage of revenues, contracted 110 bps year over year to 15.4%.Total headcount at the end of the third quarter was 349,800 compared with 343,800 in the prior quarter. Voluntary attrition - Tech Services on a trailing 12-month basis was 14.5% in the third quarter of 2025, compared with 15.2% and 14.6% for the periods ended June 30, 2025, and Sept. 30, 2024, respectivelyCognizant reported a GAAP operating margin of 16%, expanding 140 bps on a year-over-year basis.Non-GAAP operating margin (adjusted for NextGen charges) of 16% expanded 70 bps year over year.CTSH’s Balance SheetCTSH had cash and short-term investments of $2.35 billion as of Sept. 30, compared with $1.80 billion as of June 30, 2025. As of Sept. 30, 2025, the company had a total debt of $584 million, down from $592 billion reported as of June 30.The company generated $1.227 billion in cash from operations compared with $398 million in the previous quarter.Free cash flow was $1.16 billion compared with $331 million reported in the prior quarter.CTSH Initiates Strong Q4 & 2025 Guidance  Cognizant expects fourth-quarter 2025 revenues between $5.27 billion and $5.33 billion, indicating growth of 3.8%-4.8% and an increase of 2.5%-3.5% on a cc basis. For 2025, revenues are expected to be in the range of $21.05-$21.10 billion, an increase of 6.6-6.9% on a reported basis and growth of 6%-6.3% on a cc basis. Adjusted operating margin for 2025 is expected to be approximately 15.7% (an increase of 40 basis points).Adjusted earnings per share for 2025 are expected to be between $5.22 and $5.26.How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates review.VGM ScoresCurrently, Cognizant has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. However, the stock has a grade of B on the value side, putting it in the second quintile for this investment strategy.Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Cognizant has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.Performance of an Industry PlayerCognizant belongs to the Zacks Computers - IT Services industry. Another stock from the same industry, Infosys (INFY), has gained 4.7% over the past month. More than a month has passed since the company reported results for the quarter ended September 2025.Infosys reported revenues of $5.08 billion in the last reported quarter, representing a year-over-year change of +3.7%. EPS of $0.20 for the same period compares with $0.19 a year ago.For the current quarter, Infosys is expected to post earnings of $0.20 per share, indicating a change of +5.3% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Infosys. Also, the stock has a VGM Score of C.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis Report American Noble Gas Inc. (INFY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Cognizant und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Cognizant

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cognizant

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Cognizant Corp.

Wer­bung

Analysen zu Cognizant Corp.

DatumRatingAnalyst
03.05.2019Cognizant HoldNeedham & Company, LLC
03.05.2019Cognizant PerformOppenheimer & Co. Inc.
07.02.2019Cognizant OutperformBMO Capital Markets
02.11.2018Cognizant Market PerformBMO Capital Markets
08.02.2018Cognizant OverweightBarclays Capital
DatumRatingAnalyst
07.02.2019Cognizant OutperformBMO Capital Markets
02.11.2018Cognizant Market PerformBMO Capital Markets
08.02.2018Cognizant OverweightBarclays Capital
08.02.2018Cognizant Strong BuyNeedham & Company, LLC
08.11.2017Cognizant BuyPivotal Research Group
DatumRatingAnalyst
03.05.2019Cognizant HoldNeedham & Company, LLC
03.05.2019Cognizant PerformOppenheimer & Co. Inc.
10.01.2017Cognizant Technology Solutions HoldLoop Capital
30.09.2016Cognizant Technology Solutions HoldArgus Research Company
09.09.2016Cognizant Technology Solutions NeutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
02.03.2009Cognizant Technology underperformWachovia Securities, LLC
18.12.2006Update Cognizant Technology Solutions Corp.: UnderHSBC Securities

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cognizant Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen